eMed

💪

Women’s health week is here. This week is your reminder to check in with your body, your mind, and your health. Start small. Stay consistent. It matters more than you think.

🎙️eMed Health Population CEO @lindayaX is now leading the charge at an up and coming GLP-1 player that just scored a big capital raise and has NFL legend @TomBrady as its founding chief wellness officer. But, the time she spent rebuilding @elonmusk's X offered up a moment of reflection when we sat down on my Power Players podcast on @YahooFinance: “When I first started [at X], I used to say that it was a career opportunity of a lifetime. And then I was there a couple of weeks and I dropped the career part and I said, it's just an opportunity of a lifetime. And again, I go back to my time of what we did, of repositioning the platform to become the global town square. And I say for the world, it was like turning a light bulb on and in a dark room. And, and so who wouldn't want to be part of that? But as you know, it was at a very tumultuous time. Transformation is always messy. And when it's messy, people that you think you've known your whole career or people that you've done business with, it takes them a little while to warm up to what you're doing. So that's why even those relationships that I talked about mattered most,” Yaccarino said. Tasked with stabilizing a platform in turmoil, Yaccarino is credited with modernizing X’s business operations, spearheading the expansion of video features and digital wallet services, and working tirelessly to bring back advertisers. Our full chat 👇 📈Yahoo Finance: finance.yahoo.com/video/why-form… 🎙️Spotify: open.spotify.com/episode/5wpD41… 🎧Apple: podcasts.apple.com/us/podcast/why… 🎵Amazon: music.amazon.com/podcasts/7b6dd…

22 million healthcare workers help keep this country healthy. Nurses are at the center of that care. This Nurses Week, we’re celebrating the nurses and clinical professionals who deliver care everyday.

@lindayaX Structure. Adherence. Outcomes. That's the eMed difference. 🚀

GLP-1 aren't expensive. Unmanaged chronic disease is. That's what @eMedHealth was built for.

@eMedHealth is headed to @MilkenInstitute! We'll be taking the stage at the Milken Institute Global Conference May 3–6, joining the world's most influential leaders to shape the future of workforce health.

Healthcare professionals keep everyone else healthy. It's time someone did the same for them. @EBNbenefitnews covers how eMed and @TomBrady are making that happen. benefitnews.com/news/tom-brady…

@EBNbenefitnews @EmedHealthtech This is our official eMed handle if you are able to edit please - thank you!

Former NFL QB Tom Brady, now chief wellness officer at @EmedHealthtech, and Linda Yaccarino, the platform’s CEO, have launched a #GLP-1 program that makes medication and clinical support more affordable for healthcare workers. #weighthealth bit.ly/4sI4yeJ

"GLP-1s are changing the health equation: way beyond a benefit and now a very smart business decision." @lindayaX

🚀

April doesn’t reflect intention, it reveals behavior. Employers that focus on consistency, not just sign-ups, are the ones that see measurable impact. Read more: emed.com/for-businesses…

Wise words! 👏

Big news at eMed. We've raised $200M at a $2B+ valuation. GLP-1s are one of the most powerful medical advances in humanity's history. But they only work when people stay on them. AI-powered. Clinically guided. Outcomes-focused. We are just getting started.

Don’t leave health to luck. 🍀 The eMed GLP-1 program begins with screening that helps guide appropriate prescribing and responsible access. We're built to help employers manage GLP-1 access while supporting their employee health.

At @SXSW, @mcuban and I shared that @eMedHealth and @costplusdrugs are working together to give eMed members access to GLP-1s through the Cost Plus Drugs Affiliate Pharmacy Network. Transparent pricing + a system designed for results. This is healthcare disruption.

@lindayaX @sxsw @mcuban 💪

Disruption only matters if it leads to real transformation. At @SXSW I’ll join @mcuban to talk about what real healthcare disruption looks like, from fixing drug pricing and building the systems that make GLP-1 breakthroughs actually improve lives.

@lindayaX 💪🏼

Calling GLP-1s a “shortcut” is lazy. What’s harder is understanding how behavior change actually works. Without support, discipline doesn’t stick. With the right program in place, better health follows. @eMedHealth

We’re excited to announce a new partnership between eMed and Beyond Med. Together, we’re expanding access to the eMed GLP-1 program, opening the door to FDA approved, branded GLP-1 medications delivered through a structured program led by licensed clinicians. Members receive real guidance, ongoing support designed for lasting results and long term health.

Did you know GLP-1 therapy is linked to reductions in inflammation markers?

The eMed GLP-1 program is here. Built for employers, designed for outcomes you can track. Learn more at emed.com/for-businesses…